America - The product is a fixed dose combination of paracetamol, phenylephrine and caffeine, which was banned by India’s health ministry.
Published: Tue 15 Mar 2016, 7:42 AM
Updated: Tue 15 Mar 2016, 2:12 PM
US consumer health giant Procter & Gamble’s India unit said on Tuesday it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk.
The product is a fixed dose combination of paracetamol, phenylephrine and caffeine, which was banned by India’s health ministry in a notice issued over the weekend, Procter & Gamble Hygiene and Health Care Ltd informed the stock exchange.